BMS Receives EC Approval for Opdivo-based Perioperative Regimen in NSCLC
Bristol-Myers Squibb (BMS; NYSE: BMY) announced last week that it has received marketing authorization from...
Others
AbbVie Pays $335 Million Upfront to ADARx for Next-Gen siRNA Therapeutics
US-based pharma giant AbbVie (NYSE: ABBV) has entered into a significant collaboration with ADARx Pharmaceuticals,...
Roche’s Q1 2025 Results: Pharma Sales Drive 8% Growth Amidst Flat Diagnostics
Swiss pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) reported Q1 2025 financials with global group...